09. 13(Sat)
09. 13(Sat) 08:50~10:10 Room 3
Optimized Management of Cardiometabolic Syndrome in the Elderly: Focus on Multimorbidity and Frailty
- Strategies for managing hyperlipidemia in fragile elderly patients 08:50~09:10
- Optimizing glucose control in fragile elderly patients with cardiometabolic syndrome 09:10~09:30
- How to deal with multimorbidity and frailty for the prevention of cardiovascular disease 09:30~09:50
- Panel Discussion 09:50~10:20
09. 13(Sat) 08:50~10:20 Room 4
From Treatment to Prevention: A Paradigm Shift in Obesity
09. 13(Sat) 14:50~16:20 Room 1
09. 13(Sat) 14:50~16:20 Room 3
Atherosclerosis Beyond Traditional Risks: Emerging Clinical Challenges in Comorbid Conditions
- Atherosclerosis and lipid management in cancer survivors: balancing cardiovascular and oncologic risks 14:50~15:10
- Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk equivalent 15:10~15:30
- Atherosclerosis in chronic inflammatory diseases: focus on rheumatoid arthritis and systemic autoimmunity 15:30~15:50
- Panel Discussion 15:50~16:20
09. 13(Sat) 14:50~16:20 Room 4
TBD
09. 13(Sat) 16:20~17:50 Room 1
Dyslipidemia Management in Special Populations
09. 13(Sat) 16:20~17:50 Room 3
Emerging Therapeutics Targeting Myocardial-vascular Interaction in Atherosclerotic Disease
- IKKε-deficient macrophages impede cardiac repair after myocardial infarction by enhancing the macrophage-myofibroblast transition 16:20~16:40
- Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis 16:40~17:00
- Roles of MCU in human platelets on platelet aggregation 17:00~17:20
- Panel Discussion 17:20~17:50
